期刊
ANTIVIRAL RESEARCH
卷 107, 期 -, 页码 23-30出版社
ELSEVIER SCIENCE BV
DOI: 10.1016/j.antiviral.2014.03.012
关键词
Hepatitis C; Liver fibrosis; Sustained virological response; Stellate cells; Fibrosis regression
资金
- NIAAA NIH HHS [R01 AA020709] Funding Source: Medline
- NIDDK NIH HHS [R01 DK056621] Funding Source: Medline
A sustained virological response (SVR) from HCV (synonymous with virological cure) leads to decreased mortality, morbidity and improved quality of life, as well as a reduced incidence of liver disease progression, including liver failure, cirrhosis and hepatocellular carcinoma. Large clinical trials comparing pre- and post-treatment liver biopsies demonstrate improvements in inflammation as well as fibrosis score following SVR. However, a small subset of patients display persistent hepatic inflammation and/or progress to cirrhosis despite SVR. In addition to conferring a risk of fibrosis progression, advanced fibrosis pre-treatment is a major risk factor for post-SVR hepatocellular carcinoma. In this review, we discuss the mechanisms of fibrosis regression uncovered using experimental fibrosis models and highlight potential mechanisms in those few patients with fibrosis progression despite SVR. We also introduce current concepts of fibrosis-dependent tumorigenesis post-SVR in patients with advanced disease. This article forms part of a symposium in Antiviral Research on Hepatitis C: next steps toward global eradication. (C) 2014 Elsevier B.V. All rights reserved.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据